APA (7th ed.) Citation

Kubo, T., Kato, H., Horiguchi, S., Kozuki, T., Asagi, A., Yoshida, M., . . . Hotta, K. (2025). Phase-Ib dose-finding and pharmacokinetic trial of metformin combined with nivolumab for refractory/recurrent solid tumors. International Journal of Clinical Oncology, 1-8. https://doi.org/10.1007/s10147-025-02786-2

Chicago Style (17th ed.) Citation

Kubo, Toshio, Hironari Kato, Shigeru Horiguchi, Toshiyuki Kozuki, Akinori Asagi, Michihiro Yoshida, Heiichiro Udono, Katsuyuki Kiura, and Katsuyuki Hotta. "Phase-Ib Dose-finding and Pharmacokinetic Trial of Metformin Combined with Nivolumab for Refractory/recurrent Solid Tumors." International Journal of Clinical Oncology 2025: 1-8. https://doi.org/10.1007/s10147-025-02786-2.

MLA (9th ed.) Citation

Kubo, Toshio, et al. "Phase-Ib Dose-finding and Pharmacokinetic Trial of Metformin Combined with Nivolumab for Refractory/recurrent Solid Tumors." International Journal of Clinical Oncology, 2025, pp. 1-8, https://doi.org/10.1007/s10147-025-02786-2.